Home/Filings/4/0001493152-22-019871
4//SEC Filing

Wendel Bruce 4

Accession 0001493152-22-019871

CIK 0000109657other

Filed

Jul 18, 8:00 PM ET

Accepted

Jul 19, 9:42 PM ET

Size

7.6 KB

Accession

0001493152-22-019871

Insider Transaction Report

Form 4
Period: 2022-07-15
Wendel Bruce
Director
Transactions
  • Award

    Option to purchase Common Stock

    2022-07-15+50,00050,000 total
    Exercise: $2.48From: 2022-07-15Exp: 2032-07-14Common Stock (50,000 underlying)
  • Award

    Option to purchase Common Stock

    2022-07-15+50,00050,000 total
    Exercise: $2.48Exp: 2032-07-14Common Stock (50,000 underlying)
Footnotes (1)
  • [F1]1/4th of the shares vest on the date of grant and on each of September 8, 2022, December 8, 2022 and March 8, 2023.

Documents

1 file

Issuer

GT Biopharma, Inc.

CIK 0000109657

Entity typeother

Related Parties

1
  • filerCIK 0001364846

Filing Metadata

Form type
4
Filed
Jul 18, 8:00 PM ET
Accepted
Jul 19, 9:42 PM ET
Size
7.6 KB